Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06445946Phase 4Recruiting
A Phase 4 trial of liquid metformin (Aspargo Labs) in gestational diabetes mellitus (GDM), sponsored by The Ohio State University. Started Aug 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06445946.